UCB S.A.: all 580 studies

Page 3 of 6. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• Prostaglandin E1 in Outpatients With Intermittent ClaudicationCompletedNCT01263925Phase 3Results posted
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus ErythematosusCompletedNCT01262365Phase 3Results posted
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)CompletedNCT01261793Phase 3Results posted
• Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresCompletedNCT01261325Phase 3Results posted
• A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis SubjectsCompletedNCT01255761Phase 4Results posted
• Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and OlderCompletedNCT01243177Phase 3Results posted
• Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and OlderCompletedNCT01236001Results posted
• Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)CompletedNCT01235598Phase 3Results posted
• Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset SeizureCompletedNCT01235403Phase 4Results posted
• Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset SeizuresCompletedNCT01229735Phase 4Results posted
• A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)CompletedNCT01228747Phase 3Results posted
• Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral SolutionCompletedNCT01210690Results posted
• Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab PegolCompletedNCT01190410Phase 2Results posted
• Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal PatchCompletedNCT01159691Results posted
• Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyCompletedNCT01118962Phase 2Results posted
• Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyCompletedNCT01118949Phase 2Results posted
• Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic PainCompletedNCT01115569Phase 3Results posted
• Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily PractiseCompletedNCT01113710Results posted
• Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic DrugCompletedNCT01098162Results posted
• Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisCompletedNCT01087788Phase 3Results posted
• Certolizumab Pegol in Subjects With Active Axial SpondyloarthritisCompletedNCT01087762Phase 3Results posted
• Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back PainCompletedNCT01081912Phase 3Results posted
• Observation of Treatment With Certolizumab Pegol in Daily PracticeCompletedNCT01069419Results posted
• An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial SeizuresCompletedNCT01063764Phase 3Results posted
• Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the BodyCompletedNCT01059903Phase 1Results posted
• Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of MigraineCompletedNCT01016834Phase 4Results posted
• Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal VaccinesCompletedNCT00993668Phase 4Results posted
• Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With EpilepsyCompletedNCT00961441Phase 2Results posted
• Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the BodyCompletedNCT00957944Phase 1Results posted
• Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset SeizuresCompletedNCT00955357Phase 4Results posted
• An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With EpilepsyCompletedNCT00938912Phase 2Results posted
• A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial SeizuresCompletedNCT00938431Phase 2Results posted
• The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and AdolescentsTerminatedNCT00899678Phase 2Results posted
• Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.CompletedNCT00881894Phase 1Results posted
• Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)CompletedNCT00845663Phase 1Results posted
• SECURE, the Cimzia ® Crohn's Disease Post-Marketing RegistryCompletedNCT00844285Results posted
• Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedNCT00843778Phase 3Results posted
• Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset SeizuresCompletedNCT00771927Results posted
• An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of BrivaracetamCompletedNCT00761774Phase 3Results posted
• Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)CompletedNCT00753454Phase 3Results posted
• Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00717236Phase 3Results posted
• A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresTerminatedNCT00699283Phase 3Results posted
• A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset SeizuresTerminatedNCT00698581Phase 3Results posted
• Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedNCT00674362Phase 3Results posted
• Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset SeizuresCompletedNCT00655551Phase 3Results posted
• Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset SeizuresCompletedNCT00655486Phase 3Results posted
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisCompletedNCT00653224Phase 4Results posted
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 MonthsCompletedNCT00628108Phase 3Results posted
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisCompletedNCT00621959Phase 4Results posted
• A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site SignsCompletedNCT00620425Phase 1Results posted
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown OriginCompletedNCT00619801Phase 3Results posted
• Alprostadil in Maculopathy Study (AIMS)TerminatedNCT00619229Phase 3Results posted
• Transdermal Rotigotine User Surveillance StudyCompletedNCT00599339Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's DiseaseCompletedNCT00599196Phase 3Results posted
• Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IVCompletedNCT00596752Phase 4Results posted
• A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing SurgeryCompletedNCT00594464Phase 4Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's DiseaseCompletedNCT00594386Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.CompletedNCT00594165Phase 3Results posted
• Safety and Tolerability Trial of Switching From Ropinirole to RotigotineCompletedNCT00593606Phase 3Results posted
• Dosing Flexibility Study in Patients With Rheumatoid ArthritisCompletedNCT00580840Phase 4Results posted
• A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's DiseaseCompletedNCT00552344Phase 3Results posted
• To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresCompletedNCT00552305Phase 2Results posted
• Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's DiseaseCompletedNCT00552058Phase 3Results posted
• Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.CompletedNCT00546351Phase 3Results posted
• Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With EpilepsyCompletedNCT00535392Phase 2Results posted
• Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset SeizuresCompletedNCT00530855Phase 3Results posted
• Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal PatchCompletedNCT00522379Phase 3Results posted
• Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresCompletedNCT00522275Phase 3Results posted
• Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset SeizuresCompletedNCT00520741Phase 3Results posted
• Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseTerminatedNCT00519532Phase 3Results posted
• Assess Safety and Efficacy of Lacosamide in Patients With Partial SeizuresCompletedNCT00515619Phase 3Results posted
• Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With EpilepsyCompletedNCT00505934Phase 2Results posted
• An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's DiseaseCompletedNCT00505687Phase 3Results posted
• Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From EpilepsyCompletedNCT00504881Phase 3Results posted
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's DiseaseCompletedNCT00501969Phase 3Results posted
• Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)CompletedNCT00498186Phase 2Results posted
• Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresCompletedNCT00490035Phase 3Results posted
• Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the KneeTerminatedNCT00485472Phase 2Results posted
• Randomized Evaluation of the 24-Hour Coverage: Efficacy of RotigotineCompletedNCT00474058Phase 3Results posted
• The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.CompletedNCT00464737Phase 2Results posted
• Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresCompletedNCT00464269Phase 3Results posted
• A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine ProphylaxisCompletedNCT00440518Phase 2Results posted
• Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.CompletedNCT00422422Phase 2Results posted
• Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial SeizuresCompletedNCT00419393Phase 3Results posted
• Conversion to Monotherapy Study With Keppra XR for Partial SeizuresCompletedNCT00419094Phase 3Results posted
• Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.CompletedNCT00401830Phase 2Results posted
• Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS SymptomsCompletedNCT00389831Phase 2Results posted
• Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and EczemaCompletedNCT00375713Phase 3Results posted
• Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and AdultsCompletedNCT00368251Phase 3Results posted
• A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XRCompletedNCT00368069Phase 3Results posted
• A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset SeizuresCompletedNCT00367432Phase 3Results posted
• Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's DiseaseCompletedNCT00356408Phase 3Results posted
• A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic NeuropathyCompletedNCT00350103Phase 3Results posted
• Corticosteroid Sparing Effect of Certolizumab in Crohn's DiseaseTerminatedNCT00349752Phase 3Results posted
• Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine ChangesCompletedNCT00345800Phase 1Results posted
• Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's DiseaseCompletedNCT00333788Phase 3Results posted
• Maintenance Study of Certolizumab Pegol (CZP) in Crohn's DiseaseCompletedNCT00329550Phase 2Results posted
• Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)CompletedNCT00329420Phase 2Results posted
• Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque PsoriasisCompletedNCT00329303Phase 2Results posted
• Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to InfliximabCompletedNCT00308581Phase 3Results posted

← UCB S.A. overview and focus areas